A Multicenter Open-label Extension Study To Assess Long-term Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera Ii)

Trial Profile

A Multicenter Open-label Extension Study To Assess Long-term Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera Ii)

Completed
Phase of Trial: Phase II

Latest Information Update: 25 Nov 2016

At a glance

  • Drugs SHP 647 (Primary)
  • Indications Crohn's disease
  • Focus Adverse reactions
  • Acronyms OPERA II
  • Sponsors Pfizer
  • Most Recent Events

    • 30 Aug 2016 Status changed from active, no longer recruiting to completed.
    • 31 May 2016 Planned End Date changed from 1 Jun 2017 to 1 Jul 2016.
    • 31 May 2016 Planned primary completion date changed from 1 Jun 2017 to 1 Jul 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top